- Bamlanivimab Emergency Use Authorization Letter
- Fact Sheet for Healthcare Providers: EUA of Bamlanivimab
- Pending FDA Emergency Use Authorization for Antibody Infusion – Informational Call with TDH Recording | Slides
- New England Journal of Medicine Article – SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- Medicare Monoclonal Antibody COVID-19 Infusion Program Instructions
- Facility Criteria For Bamlanivimab Use Under FDA Emergency Use Authorization (EUA)
- Bamlanivimab Allocation and Distribution FAQs